André Leoni is currently the Ophthalmology and Retina Business Unit Executive Leader at Bayer, a position held since 2024. From 2018 to 2024, André served as a Senior Product Manager in Ophthalmology at Bayer Pharmaceuticals, where they led the Eylia strategy and collaborated closely with medical and market access teams. Prior to this, André held various roles at Sanofi, including Diabetes Product Manager, where they managed KOL relationships and developed educational programs. André's educational background includes an Executive MBA from MBA USP/Esalq, along with additional qualifications in negotiations and health policy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices